Gene Symbol | Gene ID | Gene Info |
---|---|---|
Neurod2
|
ENSMUSG00000038255.6 | neurogenic differentiation 2 |
Bhlha15
|
ENSMUSG00000052271.7 | basic helix-loop-helix family, member a15 |
Bhlhe22
|
ENSMUSG00000025128.6 | basic helix-loop-helix family, member e22 |
Olig1
|
ENSMUSG00000046160.5 | oligodendrocyte transcription factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr5_144189922_144190107 | Bhlha15 | 272 | 0.877397 | -0.69 | 4.2e-09 | Click! |
chr5_144190139_144190318 | Bhlha15 | 58 | 0.963295 | -0.68 | 1.1e-08 | Click! |
chr5_144184112_144184292 | Bhlha15 | 6084 | 0.147127 | -0.51 | 8.4e-05 | Click! |
chr5_144184452_144184603 | Bhlha15 | 5759 | 0.148686 | -0.42 | 1.5e-03 | Click! |
chr5_144190792_144190943 | Bhlha15 | 581 | 0.668360 | -0.39 | 3.4e-03 | Click! |
chr3_18058337_18058498 | Bhlhe22 | 4243 | 0.225354 | 0.65 | 9.5e-08 | Click! |
chr3_18052475_18052783 | Bhlhe22 | 1545 | 0.401197 | 0.64 | 1.4e-07 | Click! |
chr3_18058615_18058790 | Bhlhe22 | 4528 | 0.220898 | 0.63 | 2.0e-07 | Click! |
chr3_18054074_18054270 | Bhlhe22 | 2 | 0.979125 | 0.63 | 2.6e-07 | Click! |
chr3_18053851_18054070 | Bhlhe22 | 214 | 0.939803 | 0.62 | 4.0e-07 | Click! |
chr11_98321236_98321413 | Neurod2 | 8324 | 0.095549 | 0.73 | 1.8e-10 | Click! |
chr11_98320472_98320623 | Neurod2 | 9101 | 0.094413 | 0.67 | 2.7e-08 | Click! |
chr11_98329174_98329333 | Neurod2 | 395 | 0.721021 | 0.65 | 8.3e-08 | Click! |
chr11_98334111_98334362 | Neurod2 | 4588 | 0.104472 | 0.62 | 3.7e-07 | Click! |
chr11_98329343_98329728 | Neurod2 | 113 | 0.926820 | 0.60 | 1.1e-06 | Click! |
chr16_91269851_91270032 | Olig1 | 169 | 0.924779 | 0.58 | 3.3e-06 | Click! |
chr16_91270204_91270355 | Olig1 | 507 | 0.702636 | 0.55 | 1.2e-05 | Click! |
chr16_91266171_91266336 | Olig1 | 3519 | 0.152920 | 0.41 | 1.8e-03 | Click! |
chr16_91292688_91293239 | Olig1 | 23191 | 0.106585 | 0.36 | 6.7e-03 | Click! |
chr16_91269570_91269822 | Olig1 | 76 | 0.956636 | 0.29 | 3.2e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_87745290_87745662 | 30.71 |
Msh2 |
mutS homolog 2 |
48935 |
0.12 |
chr11_44977922_44978106 | 28.74 |
Ebf1 |
early B cell factor 1 |
65876 |
0.13 |
chr5_110611527_110611728 | 25.66 |
Galnt9 |
polypeptide N-acetylgalactosaminyltransferase 9 |
8105 |
0.13 |
chr3_51096175_51096378 | 25.63 |
Gm38246 |
predicted gene, 38246 |
7384 |
0.2 |
chr2_20476541_20476842 | 25.06 |
Etl4 |
enhancer trap locus 4 |
33356 |
0.19 |
chr3_50044774_50044968 | 24.73 |
Gm37826 |
predicted gene, 37826 |
15202 |
0.23 |
chr14_62455363_62455547 | 23.29 |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
662 |
0.68 |
chr4_87928972_87929158 | 23.23 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
54523 |
0.14 |
chr4_79310443_79310594 | 22.64 |
Gm11263 |
predicted gene 11263 |
17190 |
0.27 |
chr12_66889371_66889522 | 21.68 |
Gm18940 |
predicted gene, 18940 |
43856 |
0.16 |
chr13_83736071_83736420 | 21.65 |
Gm33366 |
predicted gene, 33366 |
2290 |
0.18 |
chr4_111866796_111866947 | 21.54 |
Slc5a9 |
solute carrier family 5 (sodium/glucose cotransporter), member 9 |
13756 |
0.18 |
chr1_24226131_24226533 | 21.40 |
Col9a1 |
collagen, type IX, alpha 1 |
3185 |
0.33 |
chr9_73258155_73258537 | 21.28 |
Gm27211 |
predicted gene 27211 |
65863 |
0.09 |
chr6_61296445_61296613 | 21.27 |
Ccser1 |
coiled-coil serine rich 1 |
14326 |
0.26 |
chr10_7268395_7268800 | 21.20 |
Cnksr3 |
Cnksr family member 3 |
56360 |
0.14 |
chr3_42892344_42892576 | 20.94 |
Gm38044 |
predicted gene, 38044 |
306861 |
0.01 |
chr13_110094450_110094601 | 20.75 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
159213 |
0.04 |
chr7_51784299_51784690 | 20.60 |
Gm29296 |
predicted gene 29296 |
11768 |
0.17 |
chr13_77295666_77295844 | 20.55 |
2210408I21Rik |
RIKEN cDNA 2210408I21 gene |
102721 |
0.07 |
chr14_73425532_73425687 | 20.41 |
Itm2b |
integral membrane protein 2B |
40320 |
0.14 |
chr6_85218363_85218514 | 20.16 |
Emx1 |
empty spiracles homeobox 1 |
24919 |
0.12 |
chr1_176994684_176995057 | 19.93 |
Sdccag8 |
serologically defined colon cancer antigen 8 |
3139 |
0.19 |
chr6_93849326_93849529 | 19.56 |
Gm22840 |
predicted gene, 22840 |
41188 |
0.16 |
chr14_98810236_98810397 | 19.55 |
Gm27034 |
predicted gene, 27034 |
95503 |
0.07 |
chr16_27925838_27926060 | 19.50 |
Gm49765 |
predicted gene, 49765 |
44396 |
0.17 |
chr14_79905756_79905979 | 19.00 |
Gm49542 |
predicted gene, 49542 |
7400 |
0.17 |
chr7_73917720_73918558 | 18.96 |
Gm45003 |
predicted gene 45003 |
29395 |
0.14 |
chr15_85991573_85992022 | 18.93 |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
13067 |
0.2 |
chr3_13725513_13725805 | 18.88 |
Gm2474 |
predicted gene 2474 |
24295 |
0.2 |
chr1_82261369_82261537 | 18.74 |
Gm9747 |
predicted gene 9747 |
28341 |
0.15 |
chr2_43097974_43098138 | 18.58 |
Gm24350 |
predicted gene, 24350 |
289021 |
0.01 |
chr19_59542425_59542623 | 18.52 |
Gm18161 |
predicted gene, 18161 |
2073 |
0.35 |
chr1_25086090_25086253 | 18.46 |
Gm29414 |
predicted gene 29414 |
58939 |
0.11 |
chr15_95216740_95217275 | 18.41 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
54613 |
0.17 |
chr8_53892879_53893080 | 18.32 |
Gm19921 |
predicted gene, 19921 |
18760 |
0.29 |
chr19_19306553_19306736 | 18.12 |
Gm41815 |
predicted gene, 41815 |
30173 |
0.17 |
chr18_72949026_72949703 | 18.08 |
Gm31908 |
predicted gene, 31908 |
28274 |
0.23 |
chr6_146282139_146282319 | 18.03 |
Gm44086 |
predicted gene, 44086 |
11249 |
0.21 |
chr1_127537694_127537960 | 17.99 |
Tmem163 |
transmembrane protein 163 |
397 |
0.9 |
chr13_114131052_114131240 | 17.80 |
Gm47479 |
predicted gene, 47479 |
10730 |
0.21 |
chr2_51753056_51753280 | 17.77 |
Gm13490 |
predicted gene 13490 |
21159 |
0.21 |
chr3_17847688_17847864 | 17.64 |
Gm23441 |
predicted gene, 23441 |
44029 |
0.13 |
chr16_64332652_64332830 | 17.28 |
Csnka2ip |
casein kinase 2, alpha prime interacting protein |
146407 |
0.05 |
chr2_79456556_79457006 | 17.25 |
Cerkl |
ceramide kinase-like |
4 |
0.51 |
chr9_27091470_27091656 | 17.24 |
Gm48796 |
predicted gene, 48796 |
6988 |
0.16 |
chrX_10268865_10269016 | 17.23 |
Otc |
ornithine transcarbamylase |
16573 |
0.24 |
chr6_51057202_51057641 | 17.02 |
Gm44402 |
predicted gene, 44402 |
90153 |
0.08 |
chr18_67483796_67483986 | 17.01 |
Prelid3a |
PRELI domain containing 3A |
11019 |
0.14 |
chr3_81025915_81026237 | 16.81 |
Gm42476 |
predicted gene 42476 |
6878 |
0.16 |
chr16_89538151_89538450 | 16.74 |
Krtap7-1 |
keratin associated protein 7-1 |
29977 |
0.13 |
chr17_49867296_49868004 | 16.72 |
Kif6 |
kinesin family member 6 |
19978 |
0.17 |
chr4_70810746_70810927 | 16.35 |
Gm11227 |
predicted gene 11227 |
261837 |
0.02 |
chr16_67611348_67611518 | 16.24 |
Cadm2 |
cell adhesion molecule 2 |
9060 |
0.25 |
chr3_49586604_49586760 | 16.05 |
Gm38261 |
predicted gene, 38261 |
16879 |
0.15 |
chr6_78278244_78278621 | 16.05 |
Gm5576 |
predicted pseudogene 5576 |
62554 |
0.11 |
chr1_114862898_114863053 | 16.01 |
Gm4854 |
predicted gene 4854 |
356788 |
0.01 |
chr1_134024711_134024876 | 16.00 |
Gm18970 |
predicted gene, 18970 |
8585 |
0.15 |
chr12_36793777_36793975 | 15.98 |
Mir5099 |
microRNA 5099 |
22329 |
0.23 |
chr13_103806232_103806601 | 15.90 |
Srek1 |
splicing regulatory glutamine/lysine-rich protein 1 |
31808 |
0.2 |
chr1_9629816_9630624 | 15.73 |
2610203C22Rik |
RIKEN cDNA 2610203C22 gene |
872 |
0.51 |
chr1_32463374_32463525 | 15.71 |
Gm37999 |
predicted gene, 37999 |
10308 |
0.17 |
chr1_184906179_184906406 | 15.62 |
Gm38251 |
predicted gene, 38251 |
16844 |
0.16 |
chr5_8224017_8224168 | 15.56 |
Gm23993 |
predicted gene, 23993 |
18631 |
0.17 |
chr10_64544466_64544617 | 15.45 |
Gm23854 |
predicted gene, 23854 |
239797 |
0.02 |
chr18_55427437_55427588 | 15.35 |
Gm37828 |
predicted gene, 37828 |
88000 |
0.09 |
chr1_13858495_13858662 | 15.30 |
Gm36947 |
predicted gene, 36947 |
9459 |
0.25 |
chr1_25229305_25229684 | 15.30 |
Adgrb3 |
adhesion G protein-coupled receptor B3 |
394 |
0.81 |
chr5_44975720_44975963 | 15.27 |
Gm10205 |
predicted gene 10205 |
8401 |
0.21 |
chr6_91359766_91359963 | 15.27 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
5207 |
0.18 |
chr9_16345275_16345564 | 15.10 |
Fat3 |
FAT atypical cadherin 3 |
32812 |
0.23 |
chr7_71488400_71488557 | 14.94 |
Gm29328 |
predicted gene 29328 |
118145 |
0.05 |
chr1_152004745_152004896 | 14.85 |
1700025G04Rik |
RIKEN cDNA 1700025G04 gene |
50472 |
0.15 |
chr2_109692795_109692946 | 14.83 |
Bdnf |
brain derived neurotrophic factor |
157 |
0.96 |
chr6_140946871_140947164 | 14.81 |
Gm30524 |
predicted gene, 30524 |
8592 |
0.26 |
chr12_5239884_5240050 | 14.73 |
Gm48532 |
predicted gene, 48532 |
4003 |
0.29 |
chr16_31501543_31501802 | 14.65 |
Gm46560 |
predicted gene, 46560 |
6715 |
0.16 |
chr17_69769280_69769433 | 14.57 |
Gm49895 |
predicted gene, 49895 |
6656 |
0.3 |
chr13_95774985_95775175 | 14.50 |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
10683 |
0.19 |
chr12_47164923_47165105 | 14.47 |
Gm36971 |
predicted gene, 36971 |
28 |
0.99 |
chr6_135092918_135093069 | 14.37 |
Gprc5d |
G protein-coupled receptor, family C, group 5, member D |
25253 |
0.11 |
chr4_53896505_53896735 | 14.34 |
Gm23745 |
predicted gene, 23745 |
9076 |
0.17 |
chr16_72862040_72862193 | 14.33 |
Robo1 |
roundabout guidance receptor 1 |
114233 |
0.07 |
chrX_137806587_137806760 | 14.30 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
154953 |
0.04 |
chr5_18292979_18293130 | 14.27 |
Gm3527 |
predicted gene 3527 |
57294 |
0.15 |
chr17_12718383_12718577 | 14.19 |
Igf2r |
insulin-like growth factor 2 receptor |
17201 |
0.13 |
chr17_67011980_67012161 | 14.17 |
Gm9984 |
predicted gene 9984 |
1585 |
0.39 |
chr1_33947103_33947453 | 14.14 |
Gm28631 |
predicted gene 28631 |
16407 |
0.12 |
chr12_56234672_56234844 | 14.10 |
Gm25917 |
predicted gene, 25917 |
17686 |
0.15 |
chr1_132569720_132569871 | 14.08 |
Nfasc |
neurofascin |
17345 |
0.16 |
chr2_173406449_173406616 | 14.05 |
Gm14642 |
predicted gene 14642 |
11966 |
0.24 |
chr5_133156480_133156656 | 14.01 |
Gm42625 |
predicted gene 42625 |
286774 |
0.01 |
chr2_12777005_12777156 | 13.97 |
Gm37565 |
predicted gene, 37565 |
79663 |
0.1 |
chr2_75422935_75423116 | 13.84 |
Gm13658 |
predicted gene 13658 |
13032 |
0.2 |
chr3_137560813_137560964 | 13.74 |
Gm4861 |
predicted gene 4861 |
8266 |
0.21 |
chr10_60194914_60195323 | 13.73 |
Chst3 |
carbohydrate sulfotransferase 3 |
879 |
0.6 |
chr15_19667510_19667673 | 13.72 |
Gm49166 |
predicted gene, 49166 |
10641 |
0.27 |
chr3_137561157_137561395 | 13.69 |
Gm4861 |
predicted gene 4861 |
8654 |
0.2 |
chr14_8508784_8508935 | 13.69 |
Gm8416 |
predicted gene 8416 |
99942 |
0.07 |
chr6_22205829_22206010 | 13.67 |
Gm42573 |
predicted gene 42573 |
40015 |
0.17 |
chr2_22166043_22166194 | 13.63 |
Myo3a |
myosin IIIA |
61385 |
0.14 |
chr1_87164459_87164700 | 13.60 |
Ecel1 |
endothelin converting enzyme-like 1 |
8058 |
0.1 |
chr3_119947205_119947510 | 13.58 |
Gm18384 |
predicted gene, 18384 |
21374 |
0.24 |
chr13_83727100_83727308 | 13.49 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
902 |
0.45 |
chr10_23127243_23127394 | 13.48 |
Eya4 |
EYA transcriptional coactivator and phosphatase 4 |
12122 |
0.24 |
chr8_125080980_125081334 | 13.45 |
Disc1 |
disrupted in schizophrenia 1 |
6830 |
0.19 |
chr7_112685264_112685521 | 13.41 |
2310014F06Rik |
RIKEN cDNA 2310014F06 gene |
5311 |
0.17 |
chr6_14819892_14820231 | 13.34 |
Ppp1r3a |
protein phosphatase 1, regulatory subunit 3A |
64787 |
0.14 |
chr8_28602402_28602553 | 13.30 |
Gm26795 |
predicted gene, 26795 |
8945 |
0.28 |
chr10_63839136_63839287 | 13.28 |
Ctnna3 |
catenin (cadherin associated protein), alpha 3 |
18156 |
0.27 |
chr2_137694036_137694202 | 13.26 |
Gm14064 |
predicted gene 14064 |
30684 |
0.26 |
chr10_89913280_89913439 | 13.25 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
39687 |
0.18 |
chr17_86266136_86266331 | 13.19 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
20945 |
0.23 |
chr9_103501990_103502354 | 13.16 |
Tmem108 |
transmembrane protein 108 |
8561 |
0.11 |
chr9_106145659_106145968 | 13.15 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
2874 |
0.12 |
chr6_22189432_22189604 | 13.15 |
Cped1 |
cadherin-like and PC-esterase domain containing 1 |
53972 |
0.14 |
chr1_38418402_38418596 | 13.04 |
Gm16152 |
predicted gene 16152 |
29670 |
0.2 |
chr16_85887623_85888246 | 13.03 |
Adamts5 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
13894 |
0.25 |
chr12_50295690_50295854 | 13.03 |
Gm40418 |
predicted gene, 40418 |
175463 |
0.03 |
chr10_19277111_19277443 | 12.99 |
Gm33056 |
predicted gene, 33056 |
13712 |
0.19 |
chr2_57821060_57821224 | 12.97 |
Gm33594 |
predicted gene, 33594 |
164875 |
0.03 |
chr16_26827135_26827286 | 12.92 |
Gm20319 |
predicted gene, 20319 |
71708 |
0.12 |
chrX_129773672_129773869 | 12.86 |
Diaph2 |
diaphanous related formin 2 |
23794 |
0.27 |
chr5_5134656_5134845 | 12.83 |
Gm43623 |
predicted gene 43623 |
5357 |
0.21 |
chr3_100034692_100034843 | 12.76 |
Spag17 |
sperm associated antigen 17 |
7159 |
0.2 |
chr5_66393812_66393963 | 12.74 |
Gm16273 |
predicted gene 16273 |
36969 |
0.1 |
chr7_132212519_132212709 | 12.70 |
Cpxm2 |
carboxypeptidase X 2 (M14 family) |
57875 |
0.1 |
chr5_70501492_70501643 | 12.68 |
Gm26072 |
predicted gene, 26072 |
49380 |
0.15 |
chr4_97581822_97582075 | 12.66 |
E130114P18Rik |
RIKEN cDNA E130114P18 gene |
2648 |
0.32 |
chr14_93182695_93182874 | 12.65 |
Gm9247 |
predicted gene 9247 |
12912 |
0.21 |
chr18_25678184_25678915 | 12.60 |
0710001A04Rik |
RIKEN cDNA 0710001A04 gene |
35221 |
0.19 |
chr8_86438259_86438704 | 12.57 |
Abcc12 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 12 |
96266 |
0.07 |
chr7_117595506_117595657 | 12.50 |
Xylt1 |
xylosyltransferase 1 |
120089 |
0.06 |
chr12_36721205_36721621 | 12.46 |
Mir5099 |
microRNA 5099 |
94792 |
0.08 |
chr2_146290850_146291227 | 12.45 |
Gm14117 |
predicted gene 14117 |
14509 |
0.18 |
chr1_129180535_129180703 | 12.43 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
92683 |
0.09 |
chr8_12138028_12138179 | 12.41 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
140716 |
0.04 |
chr13_3712201_3712740 | 12.38 |
Gm47695 |
predicted gene, 47695 |
47355 |
0.1 |
chr3_10892120_10892293 | 12.37 |
Gm22795 |
predicted gene, 22795 |
83380 |
0.09 |
chr14_103613671_103614004 | 12.34 |
Slain1 |
SLAIN motif family, member 1 |
36391 |
0.16 |
chr2_126735451_126735631 | 12.31 |
Gm10774 |
predicted pseudogene 10774 |
25984 |
0.12 |
chr15_37543227_37543378 | 12.30 |
Gm49311 |
predicted gene, 49311 |
18528 |
0.17 |
chr16_23522624_23522787 | 12.28 |
Masp1 |
mannan-binding lectin serine peptidase 1 |
1890 |
0.22 |
chr5_76762265_76762416 | 12.27 |
C530008M17Rik |
RIKEN cDNA C530008M17 gene |
9972 |
0.2 |
chr6_36926604_36926923 | 12.27 |
1700111E14Rik |
RIKEN cDNA 1700111E14 gene |
10285 |
0.24 |
chr3_81025689_81025905 | 12.25 |
Gm42476 |
predicted gene 42476 |
7157 |
0.16 |
chr1_124148811_124148962 | 12.24 |
Dpp10 |
dipeptidylpeptidase 10 |
103327 |
0.08 |
chr12_67045199_67045357 | 12.02 |
Gm47987 |
predicted gene, 47987 |
77642 |
0.11 |
chr14_49311354_49311519 | 12.00 |
Slc35f4 |
solute carrier family 35, member F4 |
2773 |
0.26 |
chr9_55083363_55083565 | 12.00 |
Gm7395 |
predicted gene 7395 |
11906 |
0.13 |
chr7_91208180_91208332 | 11.99 |
Gm24552 |
predicted gene, 24552 |
34739 |
0.14 |
chr6_52366657_52366959 | 11.93 |
Gm15054 |
predicted gene 15054 |
8984 |
0.12 |
chr12_26936808_26937007 | 11.92 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
102034 |
0.08 |
chr3_49593115_49593458 | 11.91 |
Gm38261 |
predicted gene, 38261 |
10275 |
0.16 |
chr15_87876528_87876947 | 11.91 |
Mir6393 |
microRNA 6393 |
80794 |
0.1 |
chr10_110192564_110192756 | 11.89 |
Gm47340 |
predicted gene, 47340 |
52491 |
0.15 |
chr14_19974739_19974890 | 11.88 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
1879 |
0.37 |
chr8_102656545_102656696 | 11.85 |
Gm45257 |
predicted gene 45257 |
1568 |
0.4 |
chr10_25982771_25982945 | 11.79 |
Tmem200a |
transmembrane protein 200A |
34685 |
0.16 |
chr19_47211762_47211929 | 11.78 |
Gm36693 |
predicted gene, 36693 |
9813 |
0.11 |
chr2_50045161_50045326 | 11.77 |
Lypd6 |
LY6/PLAUR domain containing 6 |
21186 |
0.27 |
chr2_57672084_57672235 | 11.75 |
Gm25388 |
predicted gene, 25388 |
18337 |
0.2 |
chr8_35157815_35157966 | 11.74 |
Gm45626 |
predicted gene 45626 |
7444 |
0.15 |
chr5_4851320_4851480 | 11.73 |
Gm25037 |
predicted gene, 25037 |
3023 |
0.18 |
chr3_5210842_5211599 | 11.70 |
Gm10748 |
predicted gene 10748 |
1618 |
0.38 |
chr10_18020913_18021146 | 11.66 |
Abracl |
ABRA C-terminal like |
1849 |
0.33 |
chr4_82099352_82099560 | 11.64 |
Gm5860 |
predicted gene 5860 |
33499 |
0.16 |
chr14_113431343_113431494 | 11.61 |
Gm4487 |
predicted gene 4487 |
59242 |
0.16 |
chrX_14274069_14274220 | 11.58 |
Gm14867 |
predicted gene 14867 |
15595 |
0.23 |
chr1_66395305_66395711 | 11.58 |
Map2 |
microtubule-associated protein 2 |
8497 |
0.21 |
chr16_72772461_72772624 | 11.57 |
Robo1 |
roundabout guidance receptor 1 |
109338 |
0.08 |
chr8_70476397_70477967 | 11.53 |
Klhl26 |
kelch-like 26 |
214 |
0.86 |
chr12_5087845_5088059 | 11.53 |
Gm9110 |
predicted gene 9110 |
20504 |
0.21 |
chr14_52310967_52311148 | 11.45 |
Sall2 |
spalt like transcription factor 2 |
5266 |
0.09 |
chr9_40746773_40746948 | 11.44 |
Gm48293 |
predicted gene, 48293 |
15395 |
0.09 |
chr6_144367916_144368122 | 11.44 |
Sox5os2 |
SRY (sex determining region Y)-box 5, opposite strand 2 |
113206 |
0.07 |
chr3_124157954_124158110 | 11.44 |
Gm43731 |
predicted gene 43731 |
88205 |
0.08 |
chr7_129775214_129775514 | 11.39 |
Gm44778 |
predicted gene 44778 |
57682 |
0.14 |
chr6_28537961_28538112 | 11.39 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
23781 |
0.14 |
chr5_38583022_38583173 | 11.34 |
4930421P07Rik |
RIKEN cDNA 4930421P07 gene |
8066 |
0.18 |
chr2_65930049_65930249 | 11.34 |
Csrnp3 |
cysteine-serine-rich nuclear protein 3 |
12 |
0.98 |
chr9_50861281_50861437 | 11.33 |
Ppp2r1b |
protein phosphatase 2, regulatory subunit A, beta |
4380 |
0.18 |
chr3_153975223_153975404 | 11.31 |
Slc44a5 |
solute carrier family 44, member 5 |
1877 |
0.27 |
chr2_12883650_12883827 | 11.30 |
Pter |
phosphotriesterase related |
40303 |
0.17 |
chr12_39073634_39073815 | 11.30 |
Gm19563 |
predicted gene, 19563 |
75070 |
0.09 |
chrX_14206556_14206761 | 11.29 |
H2al1n |
H2A histone family member L1N |
4490 |
0.32 |
chr16_45999549_45999806 | 11.29 |
Plcxd2 |
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
10541 |
0.16 |
chr16_90622066_90622245 | 11.28 |
Gm23406 |
predicted gene, 23406 |
19659 |
0.13 |
chr13_110114248_110114399 | 11.26 |
Rab3c |
RAB3C, member RAS oncogene family |
165827 |
0.03 |
chr10_102878223_102878374 | 11.24 |
Gm5175 |
predicted gene 5175 |
58927 |
0.14 |
chr3_65125115_65125266 | 11.23 |
Kcnab1 |
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
15806 |
0.26 |
chr2_107290011_107290681 | 11.15 |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
293 |
0.95 |
chr4_107823697_107823884 | 11.12 |
Lrp8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
629 |
0.42 |
chr13_68998045_68998196 | 11.10 |
Gm48593 |
predicted gene, 48593 |
101 |
0.89 |
chr12_33336631_33336802 | 11.10 |
Atxn7l1 |
ataxin 7-like 1 |
8589 |
0.2 |
chr11_24005510_24005661 | 11.09 |
Gm44381 |
predicted gene, 44381 |
9070 |
0.19 |
chr2_65993351_65993776 | 11.07 |
Gm13617 |
predicted gene 13617 |
39493 |
0.15 |
chr8_127118543_127118714 | 11.07 |
Pard3 |
par-3 family cell polarity regulator |
45388 |
0.15 |
chr13_112508598_112508749 | 11.07 |
Il31ra |
interleukin 31 receptor A |
23671 |
0.15 |
chr5_131775178_131775412 | 11.01 |
Gm42442 |
predicted gene 42442 |
76942 |
0.07 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 14.8 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
4.7 | 14.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
3.6 | 14.2 | GO:0007412 | axon target recognition(GO:0007412) |
3.3 | 10.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
2.8 | 8.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
2.3 | 11.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.1 | 6.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
2.0 | 6.0 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
2.0 | 6.0 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.9 | 5.8 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.8 | 7.2 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.8 | 5.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.8 | 8.9 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.6 | 4.8 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.6 | 7.9 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
1.5 | 4.5 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.3 | 5.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.3 | 5.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 3.9 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
1.2 | 5.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
1.2 | 7.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.1 | 10.1 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.1 | 2.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.1 | 3.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.1 | 4.3 | GO:0001927 | exocyst assembly(GO:0001927) |
1.1 | 3.2 | GO:0030421 | defecation(GO:0030421) |
1.1 | 5.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.0 | 3.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.0 | 2.9 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.0 | 4.8 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.0 | 1.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.0 | 5.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.9 | 3.6 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.9 | 5.3 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.9 | 2.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.9 | 2.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.9 | 3.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.9 | 6.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 7.6 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.8 | 1.7 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.8 | 2.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.8 | 8.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 2.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.8 | 1.5 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 2.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.7 | 2.2 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.7 | 1.4 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.7 | 11.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.7 | 2.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.7 | 5.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 1.4 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.7 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 2.7 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.0 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.7 | 2.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.7 | 2.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.7 | 3.3 | GO:0080009 | mRNA methylation(GO:0080009) |
0.7 | 2.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.6 | 3.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.6 | 1.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.6 | 5.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.6 | 1.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.6 | 1.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 1.3 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.6 | 2.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.6 | 1.9 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.6 | 5.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 3.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 0.6 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.6 | 1.7 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.6 | 1.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.6 | 3.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.6 | 2.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 1.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.5 | 1.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 3.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.5 | 0.5 | GO:0045608 | negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
0.5 | 1.6 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.5 | 13.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.5 | 1.6 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.5 | 2.1 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 7.1 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 1.5 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
0.5 | 1.0 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.5 | 1.5 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.5 | 1.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.5 | 5.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 0.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.5 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.5 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 1.4 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.5 | 2.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 3.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 | 2.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.5 | 1.4 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 2.7 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 3.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 1.3 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.4 | 1.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.4 | 1.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 1.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.4 | 1.7 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.4 | 0.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.4 | 2.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 1.3 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.4 | 1.6 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.4 | 1.2 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 0.8 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
0.4 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.4 | 1.2 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.4 | 0.8 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 5.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
0.4 | 5.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.4 | 0.8 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 2.4 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.4 | 0.4 | GO:0060166 | olfactory pit development(GO:0060166) |
0.4 | 1.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 2.3 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.4 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.2 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.4 | 1.9 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 0.4 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.4 | 0.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.4 | 1.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 1.5 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 1.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.4 | 0.8 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 1.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.4 | 0.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.4 | 3.3 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.4 | 2.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 1.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 0.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.4 | 1.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.4 | 2.9 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.4 | 2.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.4 | 0.7 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
0.4 | 0.7 | GO:0060594 | mammary gland specification(GO:0060594) |
0.4 | 2.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 0.7 | GO:0009093 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.4 | 0.7 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.3 | 1.4 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.3 | 1.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.3 | 1.0 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 2.7 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.3 | 2.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.3 | 1.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.3 | 0.7 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.3 | 1.7 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 1.6 | GO:0032252 | secretory granule localization(GO:0032252) |
0.3 | 4.3 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.3 | 1.0 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.3 | 15.0 | GO:0021766 | hippocampus development(GO:0021766) |
0.3 | 1.0 | GO:1903208 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.3 | 1.3 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 1.3 | GO:0048664 | neuron fate determination(GO:0048664) |
0.3 | 1.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.3 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.3 | 0.3 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.3 | 2.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 0.6 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.3 | 0.9 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.3 | 0.3 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.3 | 1.5 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 6.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 0.9 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.3 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 6.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.3 | 1.2 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.3 | 0.9 | GO:0090135 | actin filament branching(GO:0090135) |
0.3 | 2.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.3 | 2.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 0.3 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
0.3 | 4.6 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
0.3 | 0.9 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 0.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.3 | 0.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.3 | 1.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 0.6 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.3 | 0.5 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.3 | 0.8 | GO:0019230 | proprioception(GO:0019230) |
0.3 | 1.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.3 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.5 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.3 | 0.8 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.3 | 0.8 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.5 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.3 | 0.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.3 | 0.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.3 | 1.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.3 | 1.0 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 2.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 1.6 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.3 | 2.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.3 | 0.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.8 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.3 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 0.3 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.3 | 0.8 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 2.8 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 1.3 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.3 | 1.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.2 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.2 | 0.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.2 | 1.0 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.2 | 1.9 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.2 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.2 | 0.7 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.2 | 6.5 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.2 | 3.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 1.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.2 | 0.7 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.2 | 0.2 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 1.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.2 | 5.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) negative regulation of axon guidance(GO:1902668) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.2 | 0.7 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.5 | GO:2000173 | negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.2 | 8.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 3.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.2 | 2.7 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.9 | GO:0006573 | valine metabolic process(GO:0006573) |
0.2 | 0.7 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 1.5 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.7 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.2 | 1.3 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.9 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 0.9 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.2 | 1.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 0.9 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 0.2 | GO:0014075 | response to amine(GO:0014075) |
0.2 | 0.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 1.1 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.2 | 0.2 | GO:0072177 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
0.2 | 2.5 | GO:0060004 | reflex(GO:0060004) |
0.2 | 0.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.2 | 3.1 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
0.2 | 0.6 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.2 | 1.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.2 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 3.3 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.2 | 0.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 0.4 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.2 | 0.2 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 3.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.2 | 0.6 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 1.0 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 2.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 1.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 0.4 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 0.8 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 2.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.2 | 3.0 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.8 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.2 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.2 | 0.2 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.2 | 0.2 | GO:2000118 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.6 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.4 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.2 | 0.2 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.6 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.2 | 0.4 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.2 | 0.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.5 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.4 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.5 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.2 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 0.5 | GO:0046075 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.2 | 0.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.7 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
0.2 | 0.7 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.2 | 0.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 6.6 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.2 | 0.5 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 0.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 1.0 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.2 | 0.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.2 | 0.3 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.2 | 2.0 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.7 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 0.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 0.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.2 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 1.1 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.2 | 1.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 2.1 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.2 | 0.3 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.2 | 4.7 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.2 | 0.5 | GO:0060897 | neural plate regionalization(GO:0060897) |
0.2 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 2.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.2 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
0.2 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 0.3 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 1.2 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.4 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 2.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 0.9 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0032346 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.1 | 0.3 | GO:2000618 | regulation of histone H4-K16 acetylation(GO:2000618) |
0.1 | 0.6 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.1 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.1 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.6 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.7 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
0.1 | 0.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 1.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.1 | 0.3 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.1 | 0.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.1 | 0.3 | GO:1903416 | response to glycoside(GO:1903416) |
0.1 | 0.6 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.3 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 2.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.1 | 0.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.1 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.4 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.1 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.4 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.1 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.5 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.1 | 0.8 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
0.1 | 1.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.5 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.1 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 2.6 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
0.1 | 1.0 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 2.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 1.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 8.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 0.9 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.4 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 1.0 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
0.1 | 0.1 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.4 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.2 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.5 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 2.5 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 1.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.5 | GO:0015867 | ATP transport(GO:0015867) |
0.1 | 0.1 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.1 | 0.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 2.2 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.3 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 10.6 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 1.6 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.1 | 0.3 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 12.2 | GO:0007626 | locomotory behavior(GO:0007626) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.2 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.1 | 0.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.1 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.1 | 0.4 | GO:0014856 | skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.1 | 0.1 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.1 | 1.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.2 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.1 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.1 | 0.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.6 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.1 | GO:1903660 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 1.6 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.3 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.1 | 0.2 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.1 | 0.2 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.1 | 1.4 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.1 | 0.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.1 | 0.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.1 | 0.2 | GO:0035482 | gastric motility(GO:0035482) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.2 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.1 | 0.2 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.1 | 0.1 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.1 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.3 | GO:0035627 | ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.2 | GO:0042420 | catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) |
0.1 | 0.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.4 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.7 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.6 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.1 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.2 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.1 | 0.1 | GO:0072104 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric mesenchymal cell differentiation(GO:0072162) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.1 | 0.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.1 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.1 | 0.2 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.1 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.8 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 3.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:0033866 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.1 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.4 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.2 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.1 | 0.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.4 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.4 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 1.0 | GO:0046039 | GTP metabolic process(GO:0046039) |
0.1 | 0.1 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.1 | 0.1 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.1 | 0.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.1 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.1 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.1 | 0.1 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.3 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.2 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.1 | 0.1 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.2 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.8 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.1 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.1 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.1 | 0.1 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.1 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.2 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.1 | 0.1 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.1 | 0.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.1 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.1 | 1.0 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.2 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.1 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.1 | 0.2 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
0.1 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.1 | 0.1 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.1 | 1.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.1 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.1 | 0.4 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 0.2 | GO:1903748 | negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.2 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.4 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 0.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.2 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 1.1 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.0 | 0.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.0 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.0 | 0.2 | GO:0033574 | response to testosterone(GO:0033574) |
0.0 | 1.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.0 | GO:0072160 | nephron tubule epithelial cell differentiation(GO:0072160) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.0 | 0.0 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.0 | 0.1 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) regulation of interleukin-3 production(GO:0032672) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.1 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.1 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0021932 | hindbrain radial glia guided cell migration(GO:0021932) |
0.0 | 0.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 0.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.0 | 0.0 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.0 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.2 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.2 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.3 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.1 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
0.0 | 0.0 | GO:0009204 | deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
0.0 | 0.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.0 | 0.1 | GO:0071675 | regulation of mononuclear cell migration(GO:0071675) |
0.0 | 0.3 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.0 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.0 | 0.1 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.0 | 0.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.0 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.0 | 0.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.0 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.0 | 0.1 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.0 | 0.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.1 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.0 | 0.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.1 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.0 | 0.0 | GO:0090493 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.0 | 0.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.0 | 0.1 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.0 | 0.0 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.0 | 0.2 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.0 | 0.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.1 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.4 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.0 | 0.0 | GO:0030070 | insulin processing(GO:0030070) |
0.0 | 0.1 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.0 | 0.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
0.0 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
0.0 | 0.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.0 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.2 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.0 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.0 | 0.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.0 | 0.2 | GO:0043476 | pigment accumulation(GO:0043476) |
0.0 | 0.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.1 | GO:1902932 | positive regulation of alcohol biosynthetic process(GO:1902932) |
0.0 | 0.0 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.0 | 0.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.1 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.0 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.0 | 0.1 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.0 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.2 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.0 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.0 | 0.2 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.0 | 0.0 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.0 | 0.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0030262 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
0.0 | 0.0 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.0 | 0.0 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.0 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.0 | 0.0 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.0 | 0.0 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.0 | 0.0 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.1 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.0 | 0.1 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.1 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 0.0 | GO:0045006 | DNA deamination(GO:0045006) |
0.0 | 0.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 29.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.4 | 7.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.8 | 5.5 | GO:0097441 | basilar dendrite(GO:0097441) |
1.8 | 16.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.7 | 13.5 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 14.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.2 | 6.1 | GO:0033010 | paranodal junction(GO:0033010) |
1.1 | 3.3 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 4.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
1.0 | 3.1 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 8.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.8 | 2.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.7 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.7 | 2.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.6 | 5.7 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 2.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.6 | 1.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.6 | 2.3 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.5 | 1.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 1.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 4.3 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 2.1 | GO:0030689 | Noc complex(GO:0030689) |
0.5 | 3.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.5 | 2.9 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 1.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 7.0 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 1.3 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 7.0 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 8.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.4 | 1.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.4 | 4.7 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.4 | 2.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.4 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 1.1 | GO:0036396 | MIS complex(GO:0036396) |
0.4 | 1.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.3 | 1.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 1.0 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 5.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 18.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 0.9 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 0.9 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.3 | 15.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 2.0 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.3 | 2.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 1.4 | GO:0097433 | dense body(GO:0097433) |
0.3 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 0.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.3 | 1.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 3.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 1.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 0.3 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.3 | 0.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.2 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 0.7 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.2 | 1.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 11.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.2 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 0.9 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 1.7 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.3 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.7 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 1.8 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 12.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 0.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.2 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 1.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.2 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 7.8 | GO:0034704 | calcium channel complex(GO:0034704) |
0.2 | 1.1 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 1.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 0.5 | GO:1990696 | USH2 complex(GO:1990696) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 1.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 2.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 4.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 1.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 1.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.2 | 1.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 18.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.2 | 4.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 1.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 4.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 3.6 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 1.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.5 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.6 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.8 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 11.1 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.1 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 0.9 | GO:0031045 | dense core granule(GO:0031045) |
0.1 | 0.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.3 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.8 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 1.0 | GO:0032797 | SMN complex(GO:0032797) |
0.1 | 4.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 7.5 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 0.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 1.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 0.6 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.6 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 0.1 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 3.8 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.9 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.0 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.0 | 4.4 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 1.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.8 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 11.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.5 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.1 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.0 | 0.2 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.1 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 1.4 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.4 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.0 | 3.6 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 0.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 2.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.1 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.1 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.1 | GO:0035363 | histone locus body(GO:0035363) |
0.0 | 0.1 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.4 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.0 | 0.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 0.0 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 6.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
2.2 | 15.1 | GO:0003680 | AT DNA binding(GO:0003680) |
2.1 | 6.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
2.0 | 8.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
1.9 | 5.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.8 | 7.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
1.8 | 5.3 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.8 | 16.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.7 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.6 | 8.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.5 | 7.5 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.5 | 4.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
1.5 | 4.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 7.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
1.4 | 5.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.3 | 3.9 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.3 | 6.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 6.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
1.2 | 13.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.1 | 5.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.0 | 1.0 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.0 | 7.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 6.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.9 | 2.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.9 | 2.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.9 | 2.6 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.8 | 4.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.8 | 3.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.7 | 2.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.7 | 9.2 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 1.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 3.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 1.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.6 | 18.4 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 4.9 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.5 | 2.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.5 | 1.1 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 1.6 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 7.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.5 | 1.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 4.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.5 | 8.2 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 3.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.4 | 3.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.4 | 5.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.4 | 3.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 2.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.4 | 1.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.6 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 3.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.4 | 7.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.4 | 1.8 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 2.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.4 | 7.5 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.4 | 1.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.4 | 2.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.3 | 2.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 6.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.3 | 0.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.3 | 4.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.3 | 1.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.5 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.3 | 2.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.3 | 4.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.3 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.3 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.3 | 3.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 5.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 1.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 2.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 1.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 0.8 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 2.5 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.3 | 7.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.3 | 0.8 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 1.1 | GO:0015368 | calcium:cation antiporter activity(GO:0015368) |
0.3 | 1.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.3 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 5.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.3 | 0.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.3 | 1.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.3 | 1.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 4.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 4.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.2 | 1.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.2 | 1.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.2 | 1.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 1.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.2 | 1.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 2.9 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 5.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 0.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.2 | 0.8 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 2.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 0.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 1.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 1.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.2 | 4.2 | GO:0045296 | cadherin binding(GO:0045296) |
0.2 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.2 | 4.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.2 | 10.5 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.5 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.2 | 1.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.2 | 1.4 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 2.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.2 | 0.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.2 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 0.7 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.2 | 0.8 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
0.2 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.2 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 0.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 0.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 0.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.2 | 0.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.1 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
0.1 | 0.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 2.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 1.2 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 3.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.7 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.1 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.1 | 0.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 1.0 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 2.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 1.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.7 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 1.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 1.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.6 | GO:0033265 | choline binding(GO:0033265) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 1.4 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.1 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.3 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 1.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.4 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.4 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.1 | 0.9 | GO:0018854 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.2 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.1 | 0.6 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 2.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.5 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.7 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.1 | 0.3 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 1.8 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.1 | 0.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.1 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.1 | 1.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 1.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.2 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 0.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.1 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.1 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 0.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 8.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.4 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.6 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 2.6 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.2 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.2 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.4 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.1 | 0.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.2 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.0 | 0.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.0 | 0.2 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 1.5 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 1.2 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 1.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.0 | 0.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 1.2 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.3 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.1 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.0 | 0.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.3 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.0 | 0.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.0 | 0.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.0 | 1.6 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.0 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.0 | 0.0 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.0 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.1 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 0.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.0 | 0.2 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.7 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 0.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.0 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.5 | 6.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.4 | 19.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 5.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.4 | 7.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 0.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.4 | 7.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 3.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 1.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 7.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 0.7 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 5.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 9.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 1.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.2 | 7.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 5.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.5 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 2.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.4 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 7.1 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 3.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.2 | 1.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 1.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 3.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.9 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 4.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.5 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 1.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 0.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.0 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 2.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 11.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 1.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 2.2 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.2 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.2 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 13.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.9 | 6.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.9 | 8.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.8 | 6.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.8 | 5.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.8 | 18.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 8.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.7 | 9.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.7 | 3.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.6 | 3.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 26.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 12.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.6 | 6.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 9.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 7.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.5 | 9.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 1.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.5 | 3.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 7.5 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.4 | 5.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.4 | 8.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 1.9 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 3.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 4.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 3.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.3 | 3.2 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 7.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 2.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.3 | 2.1 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 3.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 2.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.5 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.2 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
0.2 | 2.4 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.2 | 0.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.2 | 0.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 1.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 0.6 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.2 | 7.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 1.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 4.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.2 | 0.3 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.2 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 2.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 0.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 5.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 0.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 3.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 1.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.1 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 0.2 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 1.0 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 3.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.5 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.9 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 4.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.3 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.0 | 4.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.2 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.0 | 0.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.0 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |